“Breaking Down Eli Lilly’s Q4 FY2024 Earnings: A Look at Mounjaro and Zepbound”
Eli Lilly (LLY) Reports Fourth Quarter Results Overview Eli Lilly (LLY) recently reported their fourth-quarter results, which were mostly worse-than-expected. However, the drugmaker’s adjusted profit came in above estimates. Financial Performance Despite the mixed results, Eli Lilly’s adjusted profit exceeding estimates is a positive sign for the company. The drugmaker’s revenue may have fallen short…